The decline in visual function is sensitive to the G2019S mutation as dopaminergic expression of other mutations within the LRRK2 gene, known to be pathogenic or to segregate with PD, shows no significant reduction in the fERG amplitude. The gene discussed is LRRK2; the disease is Parkinson disease.